CAG nucleotide repeat profiles in persons with schizophrenia or schizoaffective disorders with and without tardive dyskinesia: Pilot study

被引:2
|
作者
Lowrimore, P
Mulvihill, D
Epstein, A
McCormack, M
Wang, YH
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Psychiat, Piscataway, NJ 08854 USA
[3] Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Pathol, Div Human Genet, Stratford, NJ 08084 USA
[4] Univ Med & Dent New Jersey, Sch Osteopath Med, Samuel L Baily Huntingtons Dis Ctr, Stratford, NJ 08084 USA
关键词
CAG repeat expansion; tardive dyskinesia; repeat expansion detection;
D O I
10.1002/ajmg.b.30006
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Tardive dyskinesia (TD) is a drug-induced syndrome of involuntary movements often associated with neuroleptic treatment of psychiatric conditions. Huntington's disease (HD) and other neurological conditions are caused by CAG nucleotide repeat expansions in specific genes. We, therefore, explore the hypothesis that TD may he related to CAG repeat expansion by using the repeat expansion detection (RED) method as a measure of CAG content without knowledge of the location of the responsible gene. The number of CAG repeats ([CAG](n)) from persons with schizophrenia or schizoaffective disorders with (n = 10) and without (n = 9) TD are determined. A comparison of [CAG]n in persons with (56.90 +/- 23.45 repeats) and without (57.00 +/- 19.35 repeats) TD was not statistically different. The total [CAG](n) was determined by combining [CAG](n) for both groups. The median of 45 repeats was used to divide the total into two groups (SG1 and SG2 with smaller and larger [CAG](n) fragments, respectively) and a means analysis of the two subgroups based on [CAG](n) demonstrated that SG1 (n = 10 samples at 45 repeats per sample, mean [CAG](n) = 45.00 +/- 0.00) was significantly smaller than SG2 (n = 9, ranging from 48 to 120 repeats, mean = 70.22 +/- 24.83; P < 0.005). Thus, this lends support to the idea of CAG repeat expansions in the study population. Results are encouraging that a larger population and a more structured subject selection process may yield more meaningful information about the relationship between CAG repeat expansion and TD. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:15 / 18
页数:4
相关论文
共 14 条
  • [1] The 3-year course of schizophrenia among persons with tardive dyskinesia and persons without
    Ascher-Svanum, Haya
    Zhu, Baojin
    Faries, Douglas
    Kinon, Bruce
    Tohen, Mauricio
    [J]. ANNALS OF NEUROLOGY, 2006, 60 : S73 - S73
  • [2] The 3-year course of schizophrenia among persons with tardive dyskinesia and persons without
    Ascher-Svanum, H
    Zhu, BJ
    Faries, DE
    Kinon, BJ
    Tohen, M
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 205S - 205S
  • [3] Tardive dyskinesia by body region in subjects with schizophrenia/schizoaffective disorder or mood disorder: findings from the KINECT 3 study
    Factor, S.
    Stacy, M.
    Burke, J.
    Yonan, C.
    Le, H.
    Liang, G.
    [J]. MOVEMENT DISORDERS, 2017, 32
  • [4] Preliminary findings of the Gemini-Tardive Dyskinesia study in a population of patients with schizophrenia & poor outcome schizoaffective disorder in Northern Ireland
    Miller, PW
    McCusker, JJ
    McIlroy, S
    O'Neill, FA
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 114 (07): : 803 - 803
  • [5] Preliminary epidemiological findings of a study looking at Tardive Dyskinesia in a population of patients with schizophrenia and poor outcome schizoaffective disorder in Northern Ireland
    Miller, PW
    O'Neill, T
    McCusker, J
    Colgan, G
    Nolan, A
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 105 (07): : 606 - 606
  • [6] Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: A pilot study
    Daniel, DG
    Goldberg, TE
    Weinberger, DR
    Kleinman, JE
    Pickar, D
    Lubick, LJ
    Williams, TS
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1996, 153 (03): : 417 - 419
  • [7] LONG-TERM EFFECTS OF VALBENAZINE ON TARDIVE DYSKINESIA IN PATIENTS WITH SCHIZOPHRENIA/SCHIZOAFFECTIVE DISORDER: RESULTS FROM AN OPEN-LABEL, ROLLOVER STUDY
    Kane, John
    Marder, Stephen
    Lindenmayer, Jean-Pierre
    Jimenez, Roland
    Farahmand, Khodayar
    Siegert, Scott
    [J]. SCHIZOPHRENIA BULLETIN, 2019, 45 : S199 - S200
  • [8] Sleep spindles in people with schizophrenia, schizoaffective disorders or bipolar disorders: a pilot study in a general population-based cohort
    Jean-Marie Petit
    Marie-Pierre F. Strippoli
    Aurélie Stephan
    Serateh Ranjbar
    José Haba-Rubio
    Geoffroy Solelhac
    Raphaël Heinzer
    Martin Preisig
    Francesca Siclari
    Kim Q. Do
    [J]. BMC Psychiatry, 22
  • [9] Sleep spindles in people with schizophrenia, schizoaffective disorders or bipolar disorders: a pilot study in a general population-based cohort
    Petit, Jean-Marie
    Strippoli, Marie-Pierre F.
    Stephan, Aurelie
    Ranjbar, Serateh
    Haba-Rubio, Jose
    Solelhac, Geoffroy
    Heinzer, Raphael
    Preisig, Martin
    Siclari, Francesca
    Do, Kim Q. Q.
    [J]. BMC PSYCHIATRY, 2022, 22 (01)
  • [10] Long-Term Effects of Valbenazine on Tardive Dyskinesia in Patients With Schizophrenia/Schizoaffective Disorder or Mood Disorder: Results From an Open-Label, Rollover Study
    Grigoriadis, Dimitri
    Marder, Stephen
    Lindenmayer, Jean-Pierre
    Verghese, Cherian
    Burke, Joshua
    Jimenez, Roland
    Farahamand, Khody
    Siegert, Scott
    [J]. NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S321 - S322